The trend of falling ROCE at Guangdong Marubi Biotechnology does not inspire confidence. However, the company's growth trends and reinvestment in its operations are encouraging. Despite these positive trends, the stock has fallen 42% over the last three years.
Core point 1. In the past three years, China's medical beauty industry has undergone earth-shaking changes, and non-surgical products occupy the mainstream 2. The brand is a marketing tool and a social contract for the legal entity to face society. Last year, it began to issue documents on supervising medical aesthetics, focusing on doctors' qualifications, marketing, and the capabilities of three types of ...
International beauty giants released their financial reports $L'OREAL(LRLCF.US)$$エスティ ローダー A(EL.US)$$資生堂 (ADR)(SSDOY.US)$ ①China's overall performance is poor, with only L'Oreal's positive growth, behind the reflection of organizational efficiency and brand matrix perfection differences. ②Effective skincare continues to overgrow, perfume demand explodes, and wash care upgrade is ready to take ...
Guangdong Marubi Biotechnologyに関するコメント
1. In the past three years, China's medical beauty industry has undergone earth-shaking changes, and non-surgical products occupy the mainstream
2. The brand is a marketing tool and a social contract for the legal entity to face society. Last year, it began to issue documents on supervising medical aesthetics, focusing on doctors' qualifications, marketing, and the capabilities of three types of ...
$L'OREAL(LRLCF.US)$ $エスティ ローダー A(EL.US)$ $資生堂 (ADR)(SSDOY.US)$
①China's overall performance is poor, with only L'Oreal's positive growth, behind the reflection of organizational efficiency and brand matrix perfection differences.
②Effective skincare continues to overgrow, perfume demand explodes, and wash care upgrade is ready to take ...
まだコメントはありません